Starling Oncology, Inc. STLN
Set alert
6.53 USD -0.12 -1.80%
At close
6.55 +0.02 +0.31%
Pre-market · Nov 2, 8:47 AM ET
6.35 Day range 6.69
2.32 52-week range 7.13
- YTD
- +83.43%
- 1 year
- +46.41%
- Open
- 6.49
- Prev close
- 6.65
- Mkt cap
- 665.51M
- Vol
- 1.42M
- Avg vol
- 1.37M
- EPS
- -0.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.35
- High
- 6.69
1M chart
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
Financials — quick view
STLN Revenue — quarterly 161.28M
STLN Net income — quarterly -8.24M
STLN EPS — quarterly -0.08
News
- Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
- Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.